Skip to content

Research paper

Vitamin D supplementation during pregnancy: Double‐blind, randomized clinical trial of safety and effectiveness

Journal of Bone and Mineral Research
Q1
Oct 2011
Citations: 781
Influential: 54
Interventional (Human) Studies
91

Study answer

What this study found

Vitamin D3 supplementation was effective, and 4000 IU/day was the most effective dose for achieving maternal and neonatal vitamin D sufficiency without identified safety concerns. Mean circulating 25(OH)D was highest in the 4000 IU group at second trimester (98.6 nmol/L) and one month prior to delivery (114.2 nmol/L), both with p < 0.0001 versus lower-dose groups. Neonatal 25(OH)D also increased with dose: 45.5 nmol/L, 57.0 nmol/L, and 66.3 nmol/L, with sufficiency by IOM criteria in 39.7%, 58.2%, and 78.6% of infants for the 400 IU, 2000 IU, and 4000 IU groups, respectively (p < 0.0001). No…

Study & population
Double-blind randomized clinical trial in pregnant women with singleton pregnancies enrolled at the Medical University of South Carolina in Charleston, South Carolina, at 12 to 16 weeks' gestation.
Intervention
Pregnant participants received a daily prenatal multivitamin containing 400 IU vitamin D plus an additional vitamin D3 (cholecalciferol) supplement of 0 IU, 1600 IU, or 3600 IU, for total vitamin D intakes of 400 IU/day, 2000 IU/day, or 4000 IU/day.
Key limitation
The trial was conducted at a single center in Charleston, South Carolina, in women with singleton pregnancies, which limits generalizability.
View sourceOpen PDF

Original abstract

The need, safety, and effectiveness of vitamin D supplementation during pregnancy remain controversial. In this randomized, controlled trial, women with a singleton pregnancy at 12 to 16 weeks' gestation received 400, 2000, or 4000 IU of vitamin D3 p…